Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-Cell interaction and neutralization of AAV-2 infection

Journal of Virology

Volumn 74, Issue 19, 2000, Pages 9281-9293

  Wobus, C E ^a   Hugle Dorr, B ^a   Girod, A ^a   Petersen, G ^a   Hallek, M ^a   Kleinschmidt, J A ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A1; MONOCLONAL ANTIBODY A20; MONOCLONAL ANTIBODY A69; MONOCLONAL ANTIBODY B1; MONOCLONAL ANTIBODY C24 B; MONOCLONAL ANTIBODY C37 B; MONOCLONAL ANTIBODY D3; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL CULTURE; EPITOPE MAPPING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CAPSID; DEPENDOVIRUS; EPITOPE MAPPING; HUMAN; MICE; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; SUPPORT, NON-U.S. GOV'T; VIRUS REPLICATION;

EID: 0033808531     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.19.9281-9293.2000     Document Type: Article

References (55)

1. Cryo-electron microscopy of viruses
2. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses
3. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'γ)2
4. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
5. Parvovirus replication
6. Serologic evidence for human infection with adenovirus-associated viruses
7. Structure, sequence, and function correlations among parvoviruses
8. Immune responses to adenovirus and adeno-associated virus in humans
9. Antibody-antigen complexes
10. Dynamin is required for recombinant adeno-associated virus type 2 infection
11. Adeno-associated virus type 2 protein interactions: Formation of pre-encapsidation complexes
12. Adeno-associated virus vectors for gene therapy
13. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
14. Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2
15. Novel tools for production and purification of recombinant adenoassociated virus vectors
16. Genetics of adeno-associated virus: Isolation and preliminary characterization of adeno-associated virus type 2 mutants
17. Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation
18. Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: Domains recognized by monoclonal antibodies that prevent receptor recognition
19. Prospects for the use of adeno-associated virus as a vector for human gene therapy
20. Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein
21. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: Implications for gene therapy and virus structure
22. Neutralization of picornaviruses: Support for the pentamer bridging hypothesis
23. Use of adeno-associated virus as a general transduction vector for mammalian cells
24. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM
25. Mapping of linear epitopes recognized by monoclonal antibodies with gene-fragment phage display libraries
26. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
27. Adeno-associated virus 2 co-receptors?
28. Integrin αVβ5 is not involved in adeno-associated virus type 2 (AAV2) infection
29. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus
30. Mapping protein-protein contact sites using cellulose-bound peptide scans
31. Mapping of the interleukin-10/interleukin-10 receptor combining site
32. Structural proteins of adenovirus-associated viruses
33. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance
34. Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries
35. Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells
36. Adeno-associated viral vectors
37. RASMOL: Biomolecular graphics for all
38. The V3-directed immune response in natural human immunodeficiency virus type I infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain
39. Libraries of peptides and proteins displayed on filamentous phage
40. Antibody-mediated neutralization of picornaviruses
41. Adeno-associated viruses having nonsense mutations in the capsid genes: Growth in mammalian cells containing an inducible amber suppressor
42. Production of recombinant adeno-associated viral vectors
43. Assembly of adeno-associated virus type 2 capsids in vitro
44. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid
45. αVβ5 integrin: A co-receptor for adeno-associated virus type 2 infection
46. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
47. An octamer of histones in chromatin and free in solution
48. Immunoreactivity of chimeric proteins carrying the HIV-1 epitope IGP bpGRAF. Correlation between predicted conformation and antigenicity
49. Genetic analysis of adeno-associated virus: Properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function
50. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope
51. Subcellular compartmentalization of adeno-associated virus type 2 assembly
52. Intermediates of adeno-associated virus type 2 assembly: Identification of soluble complexes containing Rep and Cap proteins
53. Canine parvovirus capsid structure, analyzed at 2.9 A resolution
54. Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy